Background/Aims: Diabetes mellitus (DM) has become an increasingly epidemic metabolic disease. Vascular endothelial cells play a key role in developing the cardiovascular complications of DM. The A 2B receptor is expressed in vascular endothelial cells, and may help regulate the function of endothelial cells. The aim of this study was to investigate the protective effects of oxymatrine (OMT) on human umbilical vein endothelial cells (HUVECs) from high glucoseinduced cytotoxicity. Methods: Homology modeling and molecular docking analysis were used to detect the binding sites between the adenosine A 2B receptor and OMT. HUVECs were cultured with control (5.5 mM) or elevated glucose (22.2 mM) in the presence or absence of 3 µM OMT or A 2B siRNA for 3 days. The MTS cell viability assay was used to measure the toxicity of high glucose on HUVECs and the protective effect of OMT or A 2B siRNA. The expression of the adenosine A 2B receptor and CCL5 in HUVECs was detected with real-time quantitative PCR (qPCR) and Western blotting methods in each group. Levels of IL-1β and TNF-α were measured using an enzyme-linked immunosorbent assay (ELISA) kit, and the concentration of NO was detected with the nitrate reductase method. Monocyte chemotactic activity in each group was detected using Transwell chambers. Furthermore, the phosphorylation of p38 and ERK1/2 in each group was observed through the Western blotting method. Results: Homology modeling and molecular docking analysis showed that OMT contains well-fitted binding sites to the A 2B receptor. After chronic culture at high glucose, the rate of cell viability was significantly lower than that of the control group. After co-treatment with OMT or A 2B siRNA, cell viability was significantly increased compared with the high-glucose group. The results from real-time quantitative RT-PCR (qRT-PCR) and Western blotting indicated that high glucose could increase the expression of A 2B receptors in HUVECs, an effect that was inhibited by OMT. In addition, the results revealed that the expression of CCL5, IL-1β and TNF-α was increased in the high-glucose group, and that the NO produced by HUVECs decreased due to hyperglycemia; however, co-culture with OMT or A 2B siRNA abolished these effects. Meanwhile, the chemotaxis activity of monocytes to HUVECs cultured in high-glucose medium was enhanced 2.59-fold compared to the control cells. However, the inflammatory reactions in HUVECs were completely relieved by co-treatment with OMT or A 2B siRNA. Moreover, the phosphorylation of p38 and ERK1/2 in HUVECs in the high-glucose group was significantly higher than that of the control group; these effects were reversed after co-treatment with OMT or A 2B siRNA. Conclusion: OMT may protect the HUVECs from high glucose-induced cytotoxicity through inhibitting the expression of A 2B receptor and inflammatory factors as well as decreasing the phosphorylation of p38 and ERK1/2.
Introduction
Diabetes mellitus (DM) is caused by an absolute or a relative deficiency of insulin secretion, which results in hyperglycemia and dyslipidemia. Vascular endothelial cells play a key role in the development of cardiovascular complications of diabetes [1] . They not only form a barrier that separates the inner and outer blood vessels but also act as an important organ that has the function of regulating vascular functions. Diabetic vascular endothelial dysfunction is considered to be the earliest manifestation of disease that occurs before anatomic evidence of macrovascular diseases appears [2] . Endothelial dysfunction has become an important initiating and key factor in the development of diabetic vascular complications.
The mechanism of the toxic effect of hyperglycemia or high levels of fatty acids on vascular endothelial cells remains to be fully elucidated. Using endothelial cells cultured in vitro makes it easier to observe the effects of hyperglycemia and hyperlipidemia on cell injury [3] . Cell culture has fewer interfering factors, and the results of experiments may be more meaningful [4] .
Adenosine is an important bioactive substance in the human body. Adenosine is not only involved in cellular enzyme reactions but also acts as an active ligand in regulating many cell functions [5, 6] . It has been shown that intracellular adenosine exerts its physiological role only after it reaches the extracellular adenosine receptor by diffusion or active transport. Adenosine receptors are divided into 4 subtypes: A l , A 2A , A 2B and A 3 , depending on the ability of the receptor to bind adenosine and whether its activity regulates adenosine cyclase [7, 8] .
It has been found that the A 2B receptor is expressed in vascular endothelial cells, and may regulate the function of endothelial cells [9] . White blood cells seep into endothelial cells to impair their barrier function, causing fluid loss and edema. In the late stage of inflammation during the formation of new blood vessels, A 2B receptor activation can stimulate human microvascular endothelial cells to release VEGF and fibroblast growth factor, resulting in increased endothelial cell proliferation, chemotaxis and capillary formation [10] . A 2B receptor may promote the expression and release of a variety of pro-inflammatory mediators (e.g. IL-4, IL-8, IL-6, IL-13, IL-19 and monocyte chemoattractant protein) in the pathological process of chronic lung diseases [11] . Figler et al. reported that the expression of A 2B receptor in vascular endothelial cells was increased in diabetes, leading to an increase in the secretion of inflammatory factor IL-6 [12] . At present, not much is known about the function of A 2B receptor and its implication in diabetic vascular endothelial dysfunction.
Oxymatrine (OMT) is an alkaloid with a four-ring quinazoline structure extracted from Sophora flavescens Ait. OMT has shown anti-inflammatory, antitumor, antiviral, and anti- arrhythmic effects [13, 14] . This study aimed to investigate the potential protective effect of OMT on human vascular endothelial cells against high-glucose toxicity and the underlying mechanism, with the primary goal of looking for a new target for the prevention and treatment of diabetic complications caused by vascular endothelial dysfunction.
Materials and Methods
Cell culture and treatment HUVECs (ATCC PCS-100-010) were cultured at 37°C and 5% CO 2 in RPMI 1640 (Invitrogen; Gibco, Germany), containing 10% FBS, 100 U/ml penicillin G, and 100 mg/ml streptomycin. For experiments, HUVECs were treated with high glucose to mimic diabetic conditions for 3 days. There were 6 groups in the study according to the different treatments for the cells: control glucose (5.5 mM) (control group); high glucose (22.2 mM group); high glucose (22.2 mM) + scramble siRNA (22.2 mM + scramble siRNA group); control glucose (5.5 mM) +3 μm OMT (control + OMT group); high glucose +3 μm OMT (22.2 mM + OMT group); high glucose (22.2 mM) + A 2B siRNA (22.2 mM + A 2B siRNA group).
Cell viability
An MTS assay was performed to determine cell viability and proliferation according to the manufacturer's protocol (CellTiter 96 Aqueous One Solution Cell Proliferation Assay, Promega Company) as previously described [3] . Briefly, HUVECs were seeded in 96-well plates with MTS solution for 2h. The optical density of formazan production in each well was read at 490 nm with a microplate reader (Rayto, RT-600 Microplate Reader, Shenzhen, China). For each experiment, eight individual wells of each treatment condition were tested. Each experiment was repeated three times.
Homology modeling and molecular docking analysis to detect the binding site of OMT to the A 2B receptor
Molecular docking is a computer simulation tool that attempts to predict the binding mode of a ligand in the active site of a protein. Molecular docking studies mimic the spontaneous interaction of a ligand with the protein. Molecular docking computations were performed using AutoDock vina [15] . The technique of docking is to position the ligand in different orientations and conformations within the binding site to calculate optimal binding geometries and energies. Therefore, after the docking procedure the proper conformation of the ligand in the active site of the protein is obtained and used for the calculation of molecular descriptors. For each ligand, a number of configurations called poses are generated and scored [16] . A 2B receptor was selected as the docking receptor. Homology modeling (or comparative modeling) relies on evolutionarily related structures (templates) to generate a structural model of a protein of interest (target). Through online tools of Swiss-model [17] https:// swissmodel.expasy.org/, we obtained the threedimensional structure of A 2B receptor. Input files of amino acid (A 2B receptor, NP_000667, Refseq protein number) and a ligand (OMT) were prepared with AutoDock Tools (ADT) [16] and Python scripts named prepare_ligand4.py and prepare_receptor4.py, which are associated with the AutoDock4.2 program. The Pubchem CID of the ligand (OMT) was 114850; the CAS number was 16837-52-8. The binding pocket position in target protein was specified with the ADT molecular viewer. The parameters were kept at their default values. Finally, the output files were viewed using PyMol 2.0 [18] .
A 2B receptor small interference RNA treatment The small interfering RNAs (siRNAs) specific for the A 2B receptor were purchased from RIBOBIO CO. (Guangzhou, China). siRNA oligonucleotides targeted specifically to A 2B receptor were used in this experiment [19] . There were three siRNA duplexes targeting different encoding regions of the A 2B receptor mRNA, A 2B siRNA1, A 2B siRNA2 and A 2B siRNA3, that were designed and synthesized. These siRNAs were transiently transfected into the HUVECs. Western blotting and qRT-PCR were used to confirm the efficacy of A 2B siRNA for suppression of A 2B receptor protein and mRNA. The A 2B siRNAs were transfected into cultured cells by Lipofectamine2000 (Invitrogen). In detail, the A 2B siRNAs and Lipofectamine2000 were diluted in Opti-MEM ® medium without serum, and the final concentration of A 2B siRNAs was 50 nM. The optimal A 2B siRNA was selected based on qRT-PCR and Western blotting analysis. 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR)
QRT-PCR was performed using specific primers (Sangon, Beijing, China) on an Applied Biosystems 7500 system (ABI, Waltham, American). The annealing and melting temperatures were optimized for each primer set. GAPDH was amplified to ensure cDNA integrity and to normalize expression levels. Each real-time PCR was performed in duplicates. All experiments were repeated at least three times. The oligonucleotides used for amplification were as follows: for A 2B receptor, sense 5'-ACCGAGACTTCCGCTACACTT-3' and antisense 5'-CTGACCATTCCCACTCTTGAC-3'; for CCL5, sense 5'-CCTGCTGCTTTGCCTACATT-3' and antisense 5'-CCAGACTTGCTGTCCCTCTC-3'; and for GAPDH, sense 5'-CAGGAGGCATTGCTGATGAT-3' and antisense 5'-GAAGGCTGGGGCTCATTT-3'. The PCR products were amplified using the following cycling parameters: 94°C for 5 min; followed by 35 cycles of 94°C for 30 s, 57°C for 30 s, and 72°C for 30 s; and, finally, a single cycle at 72°C for 10 min.
Western blotting
Following treatment under different culture conditions, HUVECs were harvested in lysis buffer (RIPA:PMSF:All-in-One; 100:1:1, Solarbio, China) and incubated for 30 min on ice. Protein concentrations were determined using a plate reader (Rayto, RT-600 Microplate Reader, Shenzhen, China). The same quantity of protein per lane was resolved on 12% SDS-PAGE gels, and then transferred to PVDF membranes (Millipore, Billerica, MA, USA). The membranes were blocked with 5% milk in TBS-T (0.1 M Tris-HCl, pH 7.4, 0.9% NaCl, 0.1% Tween-20) and then incubated with primary rabbit anti-antibodies against β-actin (ZSBio, Beijing, China), the phosphorylated or total forms of ERK1/2 and p38 MAPK (Cell Signaling Technology Inc, Boston, MA, USA), CCL5 (Abcam Inc., Shanghai, China) or A 2B receptor (Fisher Scientific Inc, Shanghai, China). Subsequently, the membranes were incubated with horseradish peroxidase-conjugated secondary goat anti-rabbit IgG (Sigma, MO, USA). The membranes were washed and quantitated using an enhanced chemiluminescence detection system (ECL; Amersham, Buckinghamshire, UK). The band densities were normalized against the β-actin internal control and analyzed by Image-J system software.
Determination of NO production
After HUVECs were cultured for 3 days with different treatments in 24-well culture plates, each group was set up with three wells per compound. Then, the culture solution was collected to measure the concentrations of nitric oxide (NO) by a kit supplied by Nanjing Jiancheng Bioengineering Institute. The nitrate reductase method was used in the kit to turn NO-derived nitrate into nitrite, thus, the nitrite concentrations in the culture media were assayed. The absorbance of nitrite was measured by a microplate reader (Rayto RT-6000, Ruixin) at 550nm.
The calculation formula of the concentration of NO is as follows: concentration of NO (μmol/L) = [(absorbance of treated wells − absorbance of blank wells)/ (absorbance of standard wells − absorbance of blank wells) × standard concentration (100 μmpl/L)] × dilution times of the sample before measuring.
Chemotaxis assay A monocyte chemotactic activity assay was performed in 12-well Transwell chambers fitted with 5-µm pore polycarbonate membranes (Corning Inc., USA). HUVECs were cultured in the lower chamber in the designated conditions. U937 cells loaded with BCECF-AM were added to the upper chamber at 4 × 10 6 cells/ ml and co-cultured with HUVECs in the lower chamber at 37°C for 2 h. Cells remaining in the top chamber of the filter were aspirated and the surface was washed twice with RPMI 1640 medium. The plate was then centrifuged (312 x g, 5 min) and the filter was removed. The cells were observed by fluorescence microscopy (AMG EVOS/fl). The quantitation of fluorescent cells was carried out using a fluorescence reader (Tecan infinite M200, Switzerland).
ELISA measurement of cytokine levels in the culture supernatant
The culture supernatants of cells were collected after cultivation in high glucose with different treatments for 3 days. Samples were maintained at room temperature for 30 min and centrifuged at 3000 rpm for 10 min. The culture supernatants were collected and stored at −20°C. Levels of IL-1β and TNF-α were quantified using an enzyme-linked immunosorbent assay (ELISA) kit following the manufacturer's protocol (Senxiong Co., Shanghai, China). The reactions were read using an ELISA reader (Rayto, RT-6000, USA) at 450 nm.
Statistical analysis
All results are expressed as the mean ± SEM. Differences between treatment groups were analysed by Student's t-test or, where appropriate, ANOVA followed by Dunnett's post hoc test for multiple comparisons. A P-value of < 0.05 was considered statistically significant.
Results
Homology modeling and molecular docking analysis discloses the binding site of OMT to the A 2B receptor Molecular docking of OMT on the A 2B receptor was visualized by AutoDock 4.2. The steps were as follows. Protein molecules were dehydrated and hydrogenated. After calculation of the Gibbs free energy, the pdbqt file of the A 2B receptor was produced by the Grid function of the ADT Tools toolbar. For the ligand (OMT), the parameter was set by the ADT Tools column, and the pdbqt file of OMT was saved. The docking score of the A 2B receptor and OMT (kcal/mol) showed that OMT had a perfect fit to interact with the A 2B receptor protein (see Table 1 ). The perfect match enabled the OMT to interact with the A 2B receptor (see Fig. 1 ).
Efficacy of A 2B siRNA in the interfering with the A 2B receptor in HUVECs There were three siRNA duplexes targeting different encoding regions of A 2B receptor mRNA, named A 2B siRNA1, A 2B siRNA2 and A 2B siRNA3, that were designed and synthesized. These siRNAs were transiently transfected into the HUVECs. Western blotting and qRT-PCR were used to confirm the efficacy of A 2B siRNA for suppression of A 2B receptor protein and mRNA. The results showed that transfection of the A 2B siRNA2 resulted in a significant decrease in A 2B protein and mRNA expression (see Fig. 2 ). Thus A 2B siRNA2 that targeted sequence 5′-GAAAGCTGCTGCCTTGTGA -3′was selected for further experiments.
Protective effects of OMT or A 2B siRNA on HUVECs from high glucose induced cytotoxicity
Exposure to high glucose significantly reduced the viability of HUVECs significantly, and co-culture with OMT or A 2B siRNA abolished the cytotoxicity effect of high glucose (Fig. 3) .
Effects of OMT on A 2B receptor expression in HUVECs cultured in high glucose
The expression of the A 2B receptor was measured by qRT-PCR. The results showed that in the 22.2 mM group, A 2B receptor mRNA was significantly higher than that in the control Table 1 . MOE score of A 2B docking and oxymatrine (kcal/mol). Explanation: The predicted binding affinity is in kcal/mol (energy). *rmsd: RMSD values are calculated relative to the best mode and use only movable heavy atoms. Two variants of RMSD metrics are provided, rmsd/lb (RMSD lower bound: matches each atom in one conformation with itself in the other conformation, ignoring any symmetry) and rmsd/ub (RMSD upper bound: rmsd/lb(c1, c2) = max(rmsd'(c1, c2), rmsd'(c2, c1)), and rmsd' matches each atom in one conformation with the closest atom of the same element type in the other conformation), differing in how the atoms are matched in the distance calculation. There is a strong reaction between ligand and protein when the binding affinity is higher than -6.0 kcal/mol. The rmsd/lb and rmsd/ub of models 1 to 5 are much the same, as well as of models 6-8, which indicates that those models are locating in one docking pocket. In sum, the molecular docking of oxymatrine on a modelh protein A 2B is stable (Fig. 4) . Furthermore, the A 2B receptor at the protein level was measured by Western blotting. The results showed that the expression of the A 2B receptor protein in the 22.2 mM group was significantly higher than that in the control group (p<0.01); the expression of the A 2B receptor protein in the 22.2 mM + A 2B siRNA group was significantly lower than that in the 22.2 mM + scramble siRNA group (p<0.01); the expression of the A 2B receptor protein in the Fig. A) . Enlarged view indicated that the perfect match enabled the OMT to interact with the A 2B receptor (Fig. B, C, D) . 
Effects of OMT or A 2B siRNA on the CCL5 expression of HUVECs and chemotaxis activity of monocytes to HUVECs at high glucose
The CCL5 expression in HUVECs was detected by qRT-PCR. It was found that CCL5 mRNA in the 22.2 mM group was significantly higher than that in the control group(p<0.01). The expression of CCL5 in the 22.2 mM + OMT group was significantly lower than that in the 22.2 mM group (p<0.05), and the expression of CCL5 mRNA in the 22.2 mM + A 2B siRNA group was significantly lower than that in the 22.2 mM + scramble siRNA group (Fig. 6) .
The chemotaxis activity of monocytes to HUVECs cultured in high-glucose medium was enhanced 2.59-fold compared with the control cells (Fig. 7) . The inflammatory chemotaxis reactions in HUVECs were completely relieved by co-treatment with 3 µM OMT or A 2B siRNA (Fig. 7) .
Effects of OMT or A 2B siRNA on NO production byHUVECs
The NO production by HUVECs in the high-glucose group was significantly lower than in the control group. The glucose suppressed NO production was increased significantly by co-treatment with 3 µM OMT or A 2B siRNA (Fig. 8) .
Effects of OMT or A 2B siRNA on cytokine levels in the culture supernatant
The culture supernatants of cells were collected after cultivation in high glucose with different treatments for 3 days. Levels of IL-1β and TNF-α were measured using ELISA kits. The results showed that IL-1β and TNF-α levels in the 22.2 mM group were significantly higher than in the control group. The expression levels of IL-1β and TNF-α in the 22.2 mM + OMT group were significantly lower than those in the 22.2 mM group (p<0.05), and the expression levels of IL-1β and TNF-α in the 22.2 mM + A 2B siRNA group were significantly lower than in the 22.2 mM + scramble siRNA group (p<0.01) (Fig. 9) . 
Effects of OMT A 2B siRNA on the phosphorylation of ERK1/2 and p38 in HUVECs cultured in high glucose medium
There was no significant change in total ERK1/2 MAPK protein among the 6 groups of HUVECs. In the 22.2 mM group, the level of P-ERK1/2 was significantly higher than that in the control group (p<0.01). P-ERK1/2 in the 22.2 mM+OMT group was significantly lower than that in the 22.2 mM group (p<0.01) and similarly the level of P-ERK1/2 in the 22.2 mM + A 2B siRNA group was significantly lower than that in the 22.2 mM + scramble siRNA group (p<0.01) (Fig. 10) .
There was also no significant change in total p38 MAPK protein expression in any group of HUVECs. In the 22.2 mM group, the phosphorylation of p38 was significantly higher than that in the control group (p<0.01). The phosphorylation of p38 in the 22.2 mM+OMT group 
was significantly lower than that in the 22.2 mM group (p<0.01), and the phosphorylation of p38 in the 22.2 mM + A 2B siRNA group was significantly lower than that in the 22.2 mM + scramble siRNA group (p<0.01) (Fig. 11) .
Discussion
Vascular endothelial cells play a key role in regulating the function of blood vessels. Vascular lesions directly affect the prognosis and survival of patients with DM [20, 21] . Vascular endothelial cells are involved in inflammation and immune response by secreting a series of bioactive substances, such as prostacyclin, NO, endothelin and von Willebrand factor [22] . In addition to the formation of NO which promotes vasodilation, endothelial cells also modulate the migration of leukocytes through releasing inflammatory chemokines, cytokines, and cell surface adhesion molecules [23] . Inflammation, trauma and other stress injuries stimulate endothelial cells to increase vascular permeability and adhesion molecule expression, leading to edema, adhesion of leukocytes, and a subsequent inflammatory cascade reaction [24] . At high blood glucose, vascular endothelial cells undergo pathological changes, and their secretory activity changes. The A 2B receptor plays an important role in regulating the function of vascular endothelial cells. The A 2B receptor is expressed in vascular endothelial cells and may be involved in the regulation of pro-inflammatory responses in vascular endothelial cells [25] . Studies in A 2B receptor knockout mice showed inhibition of the infiltration of neutrophils into tissues under hypoxic conditions [26, 27] . Pro-inflammatory effects of A 2B receptors have been seen in murine lung inflammation models and in patients with asthma or chronic obstructive pulmonary disease, suggesting the potential therapeutic value of targeting A 2B receptors as an anti-inflammation measure to prevent the progression of these diseases [28, 29] . It has been reported that the A 2B receptor may promote the expression and release of the inflammatory factor IL-6 by vascular endothelial cells in diabetes [12] .
OMT is an alkaloid extracted from Sophora flavescens Ait, which has shown antiinflammatory, antitumor, antiviral, and anti-arrhythmic effects [30, 31] . Thus its anti- [12] . Our current study also confirmed that the expression of the chemokine CCL5 in HUVECs was significantly increased in response to glucotoxicity. CCL5 has long been considered as a potential target to reduce macrophage infiltration into the artery wall because CCL5 can result in a localized, potent chemotactic signal [32] . Thus high glucose may increase the expression and release of chemokines and inflammatory cytokines by activating A 2B receptors, leading to vascular inflammation and damage of vascular endothelial function via promoting the adhesion and migration of immune cells. OMT intervention could effectively suppress the increased expression of A 2B receptor and CCL5 in HUVECs in the high-glucose culture.
Vascular endothelial dysfunction is the basis of diabetic vascular complications, and chronic exposure to high glucose reduces nitric oxide (NO) production from the endothelium [33] . The ultimate goal of treatment for patients with diabetes is to prevent and delay a variety of chronic complications. Improvement of endothelial cell function could be one of the effective approaches in this regard. This study showed that high-glucose culture for 3 days reduced HUVEC viability and NO production, but the damage could be significantly relieved after intervention with OMT or A 2B siRNA. This study has revealed that the expressions of pro-inflammatory genes including TNF-α, IL-6 and IL-1β were increased by LPS-induced inflammatory response in HUVECs [34] . In this study, the results also revealed that IL-1β and TNF-α levels increased significantly due to high glucose, and that OMT could reverse Fig. 10 . Effect of OMT or A 2B siRNA on phosphorylation of ERK1/2 in HUVECs cultured in high glucose medium. ERK1/2 and P-ERK1/2 at the protein level were detected by Western blotting and the stain values (integrated optical density) of P-ERK protein expression (normalized to each ERK 1/2) were quantitated using image analysis. Values are the mean ± SEM of 6 observations. **p<0.01 vs 22.2 mM group or 22.2mM + scramble siRNA. To further explore the molecular mechanism underlying the protective effect of OMT on HUVECs from high glucose toxicity, we examined the phosphorylation of ERK1/2 and p38, which control two classic MAPK pathways implicated in the responses to cell stress, inflammation and glucotoxicity. Many studies have proven that MAPKs can be activated in HUVECs by high glucose and may play key roles in the regulation of high glucose-induced inflammatory cytokine expression [3, 35] . The results showed that high glucose culture significantly increased both P-ERK1/2 and P-p38 without altering total ERK1/2 and p38 in HUVECs. Moreover, co-treatment with OMT could significantly diminish the upregulated P-ERK1/2 and P-p38 due to high glucose exposure of HUVECs. Meanwhile the A 2B siRNA treatments also had similar effects to OMT. These observations point to the important implication of activation of classical ERK1/2 and p38 MAPK pathways in high-glucose toxicity and a potential mechanism of how OMT may alleviate glucotoxicity.
Conclusion
OMT has protective effects on HUVECs against high-glucose toxicity. Glucotoxicity can increase the expression of the A 2B receptor in HUVECs. OMT can decrease the expression of the A 2B receptor in the diabetic cell model and inhibit the release of pro-inflammatory mediators such as inflammatory cytokines (CCL5) and subsequent activation of p38 and ERK1/2 MAPK signaling pathways to alleviate the toxic effects of high glucose. 
